Taken together, our data indicate that the overexpression of TXNDC12 promotes HCC metastasis through β-catenin-mediated induction of EMT and that TXNDC12 has the potential to be a prognostic factor and therapeutic target of HCC. The gene discussed is TXNDC12; the disease is hepatocellular carcinoma.